|
KIAA1919 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.79023462720806E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.98959959618605E-10 |
| Normal-vs-Stage2 |
5.27330001887094E-09 |
| Normal-vs-Stage3 |
7.02415903219844E-12 |
| Normal-vs-Stage4 |
1.30149999999496E-07 |
| Stage1-vs-Stage2 |
2.471600E-01 |
| Stage1-vs-Stage3 |
2.018400E-01 |
| Stage1-vs-Stage4 |
6.290400E-01 |
| Stage2-vs-Stage3 |
7.482000E-01 |
| Stage2-vs-Stage4 |
5.492000E-01 |
| Stage3-vs-Stage4 |
6.935400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.90878432451791E-14 |
| Normal-vs-AfricanAmerican |
2.062000E-01 |
| Normal-vs-Asian |
2.19759999999791E-05 |
| Caucasian-vs-AfricanAmerican |
1.221820E-04 |
| Caucasian-vs-Asian |
1.120230E-01 |
| AfricanAmerican-vs-Asian |
3.140300E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.05969710573595E-11 |
| Normal-vs-Female |
4.07019973280853E-11 |
| Male-vs-Female |
3.163700E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.5226000177625E-09 |
| Normal-vs-Age(41-60Yrs) |
8.31335000839317E-12 |
| Normal-vs-Age(61-80Yrs) |
9.85500014927254E-10 |
| Normal-vs-Age(81-100Yrs) |
5.395200E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.019450E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.228400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.266800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.621400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.235600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.738800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.318300E-02 |
| Classical-VS-Follicular |
3.193600E-01 |
| Classical-VS-Other |
6.132200E-01 |
| Classical-VS-Normal |
4.25179891294647E-11 |
| Tall-VS-Follicular |
4.166600E-01 |
| Tall-VS-Other |
7.799800E-01 |
| Tall-VS-Normal |
3.20250004293143E-09 |
| Follicular-VS-Other |
8.883800E-01 |
| Follicular-VS-Normal |
2.42490000301743E-08 |
| Other-VS-Normal |
6.837500E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.90989454754254E-13 |
| Normal-vs-N1 |
1.75430000526333E-08 |
| N0-vs-N1 |
6.128200E-01 |
|
|
